Eli Lilly plans to pay up to $7 billion to purchase Kelonia Therapeutics
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...
pharmaceutical
Drug manufacturers concerned about the legal risk of the FDA’s rapid review program
Six industry sources told Reuters that while more than six big pharmaceutical companies are taking part in the Trump administration's...
Wall Street sees a 130% increase in Novavax following Sanofi’s multibillion dollar investment
After revealing a multibillion-dollar agreement with French pharmaceutical company Sanofi that would enable the latter to market its Covid-19 vaccine...
AstraZeneca admits in court that its covid-19 vaccine can cause thrombosis
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9,...
